National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care

Laryngoscope

Volumn 122, Issue 3, 2012, Pages 543-551

  Gourin, Christine G ^a   Frick, Kevin D ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Level of Evidence: 2c; Nationwide Inpatient Sample; oropharyngeal neoplasms; squamous cell cancer; surgery; Volume

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; EAR NOSE THROAT SURGERY; FEMALE; GLOSSECTOMY; HOSPITAL COST; HUMAN; LARYNGECTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; OROPHARYNX CANCER; PATIENT CARE; PRIORITY JOURNAL; SURGEON; TONGUE TUMOR; TONSIL TUMOR; TREATMENT OUTCOME; WOUND COMPLICATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84857455311     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22447     Document Type: Article

References (42)

1. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137. (Pubitemid 34984604)
2. Birkmeyer JD, Sun Y, Wong SL, Stukel TA,. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-783. (Pubitemid 46684108)
3. Finlayson EV, Goodney PP, Birkmeyer JD,. Hospital volume and operative mortality in cancer surgery. A national study. Arch Surg 2003; 138: 721-725.
4. Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol 2008; 16: 3-13.
5. Birkmeyer JD, Stukey TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-2127. (Pubitemid 37464537)
6. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Eng J Med 1991; 324: 1685-1690.
7. Forastiere A, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 2003; 349: 2091-2098. (Pubitemid 37464533)
8. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group Trial 91-11. Arch Otolaryngol Head Neck Surg 2003; 129: 44-49. (Pubitemid 36074941)
9. Chen AY, Schrag N, Hao Y, Stewart A, Ward E,. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007; 117: 16-21. (Pubitemid 46066056)
10. Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. J Clin Oncol 2002; 20: 3964-3971.
11. Denittis AS, Machtay M, Rosenthal DI, et al. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol 2001; 22: 329-335. (Pubitemid 32906591)
12. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000; 88: 876-883. (Pubitemid 30091108)
13. Calais G,., Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086. (Pubitemid 30019568)
14. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
15. Richey LM, Shores CG, George J, et al. The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 2007; 136: 98-103. (Pubitemid 46037889)
16. Temam S, Pape E, Janot F, et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiation Oncology Biol Phys 2005; 62: 1078-1083. (Pubitemid 40884420)
17. Goodwin WJ Jr,. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110 (suppl 93): 1-18. (Pubitemid 30141742)
18. Zafereo ME, Hanasono MM, Rosenthal DI, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 2009; 115: 5723-5733.
19. Overview of the Nationwide Inpatient Sample. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed October 1, 2010.
20. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006; 296: 1973-1980. (Pubitemid 44631443)
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383. (Pubitemid 17055592)
22. Romano P, Roos LL, Jollis JG,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-1079.
23. Neighbors CJ, Rogers M, Shenassa ED, et al. Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer. Med Care 1997; 45: 655-663.
24. Chang DC, Shiozawa A, Nguyen LL, et al. Cost of inpatient care and its association with hospital competition. J Am Coll Surg 2011; 212: 12-19.
25. Hall BL, Hsiao EY, Majercik S, Hirbe M, Hamilton BH,. The impact of surgeon specialization on patient mortality: examination of a continuous Herfindahl-Hirschman Index. Ann Surg 2009; 249: 708-716.
26. Cost-to-charge ratio files. Available at: http://www.hcup-us.ahrq.gov/db/ state/costtocharge.jsp. Accessed March 1, 2011.
27. Newhouse RP, Mills ME, Johantgen M, Provonost PJ,. Is there a relationship between service integration and differentiation and patient outcomes? Int J Integrated Care 2003; 3: 1-13.
28. U.S. Department of Labor. Bureau of Labor Statistics. Consumer price index inflation calculator. Available at: http://www.bls.gov/bls/inflation.htm. Accessed March 1, 2011.
29. Gourin CG, Forastiere AA, Marur S, Sanguineti G, Koch WM, Bristow RE,. Volume-based trends in surgical care of patients with oropharyngeal cancer. Laryngoscope 2011; 121: 738-745.
30. Gourin CG, Forastiere AA, Marur S, Sanguineti G, Koch WM, Bristow RE,. Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care. Laryngoscope 2011; 121: 746-752.
31. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in piriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88: 890-899. (Pubitemid 26230640)
32. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76. (Pubitemid 41095116)
33. Fallai C, Bolner A, Signor M, et al. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx. Tumori 2006; 92: 41-54.
34. Yom SS, Machtay M, Biel MA, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 2005; 28: 385-392. (Pubitemid 41099544)
35. Cmelak AJ, Li S, Goldwasser MA, et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 2007; 25: 3971-3977. (Pubitemid 47477276)
36. Marur S, D'Souza G, Westra WH, Forastiere AA,. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-789.
37. Ghaferi AA, Birkmeyer JD, Dimick JB,. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009; 361: 1368-1375.
38. Ghaferi AA, Birkmeyer JD, Dimick JB,. Complications, failure to rescue, and mortality with major inpatient surgery in Medicare patients. Ann Surg 2009; 250: 1029-1034.
39. Birkmeyer JD, Skinner JS, Wennberg DE,. Will volume-based referral strategies reduce costs or just save lives? Health Aff (Millwood) 2002; 21: 234-241.
40. Lewis CM, Hessel AC, Roberts DB, et al. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg 2010; 136: 1205-1211.
41. Cheung MC, Koniaris LG, Perez EA, et al. Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol 2009; 16: 1001-1009.
42. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.